European Commission logo
Program

Innovative Interventions for Mental and Neurodevelopmental Disorders

Funds clinical trials of new drug-based therapies, paired with a complementary approach like neurostimulation or digital monitoring, for conditions such as depression, schizophrenia, PTSD and autism spectrum disorder.

This is a two-stage Research and Innovation Action call: a short first-stage outline is evaluated blind, without applicant names, before shortlisted teams submit a full second-stage proposal. The Commission expects to fund seven projects that run rigorous clinical studies into safety and efficacy and dig into the biological mechanism behind the intervention.

MedtechNeurotech

Each grant below is a distinct funding opportunity with its own eligibility, scope, and deliverables.